Medical Toxicology
HomeProductsGuidelinesBlogsNewsTox SpotlightCase StudyContact UsCommunity
Back
Occupational And Environmental Toxins

Hydrogen Sulfide Poisoning: Recognition, Rescuer Safety, Respiratory Failure, and Emergency Management

Published on 09 Nov 2026

Follow us
Medical ToxicologyMedical Toxicologymedicaltoxic.com
Guideline

Hydrogen Sulfide Poisoning: Recognition, Rescuer Safety, Respiratory Failure, and Emergency Management

  • Occupational And Environmental Toxins
  • Published on 09 Nov 2026

https://medicaltoxic.com/guidelines/hydrogen-sulfide-poisoning-management

Hydrogen sulfide (H₂S) is a rapidly acting, highly toxic gas found in sewage and wastewater systems, manure pits, petroleum and natural-gas operations, hot springs, mining, industrial processes, and environments where sulfur-containing organic matter decomposes. Severe exposure can cause abrupt loss of consciousness—the classic “knockdown” phenomenon—followed by apnea, seizures, cardiovascular collapse, pulmonary injury, and death. [1–5]

Management begins before patient contact. Hydrogen sulfide has repeatedly killed unprotected rescuers entering contaminated confined spaces, and odor cannot establish whether an atmosphere is safe. Rescue requires trained personnel, atmospheric monitoring, appropriate respiratory protection, and confined-space procedures. [1,2]

After safe removal, treatment is primarily supportive: oxygenation and ventilation, cardiovascular resuscitation, treatment of bronchospasm and pulmonary injury, seizure control, and monitoring for delayed pulmonary and neurologic complications. No antidote has proven clinical efficacy. Sodium nitrite remains controversial and must never delay resuscitation. [3–7]

Clinical reference based on the manuscript dated November 8, 2026. Author: Omid Mehrpour, MD, FACMT.

Clinical warning

High-concentration hydrogen sulfide can cause sudden collapse, apnea, cardiovascular arrest, and death within minutes. Never enter a suspected contaminated or confined space without trained rescue personnel, atmospheric monitoring, and appropriate positive-pressure SCBA; odor is not a safety indicator. After safe removal, prioritize ventilation, oxygenation, circulation, and standard resuscitation. No antidote has proven clinical efficacy; sodium nitrite must not delay lifesaving care. Any serious clinical feature occurring at any time since exposure, even if resolved, requires urgent ED assessment and the serious-exposure pathway. Concerning symptoms or high-risk circumstances also require ED assessment but do not automatically mandate admission. Do not discharge based only on a normal current appearance.

Emergency Pathway

Clinical hydrogen sulfide poisoning flowchart showing rescuer safety, emergency resuscitation, decontamination, serious-exposure triage, ED observation, and discharge criteria.
Hydrogen sulfide poisoning emergency pathway

The pathway begins with scene and rescuer safety, then protected removal, resuscitation, and any necessary decontamination in parallel. Disposition follows two sequential assessments:

Step A — Serious features at any time since exposure.

If any serious feature occurred, even if it has resolved, follow the serious-exposure pathway with urgent ED referral and hospital admission.

Step B — Concerning symptoms or high-risk exposure.

If no Step A feature occurred, evaluate the symptoms and exposure circumstances that require ED assessment. A Step B referral does not automatically require admission.

Home or scene management is considered only when neither A nor B criteria apply and individualized poison-center assessment supports it.

The observation-clock convention and home/scene eligibility criteria are MedicalToxic operational guidance, not validated clinical prediction rules.

Key Clinical Takeaways

  • Rescuer safety is the first intervention. Do not enter potentially contaminated spaces without appropriate training, atmospheric assessment, rescue capability, and respiratory protection. [1,2]

  • Never rely on odor. Loss of the characteristic rotten-egg smell can reflect olfactory fatigue rather than disappearance of hydrogen sulfide. [1–3]

  • High-concentration exposure can cause rapid knockdown, apnea, seizures, shock, dysrhythmias, cardiac arrest, and death. [3–5]

  • A serious feature that has resolved still counts. Apparent recovery after knockdown does not make the exposure minor.

  • There is no proven antidote. Supportive cardiopulmonary care remains the treatment foundation; sodium nitrite is not routine therapy. [3–7]

  • Do not automatically transfer cyanide-antidote algorithms to H₂S poisoning.

  • Gas-only exposure generally creates little secondary-contamination risk after safe removal, whereas liquid H₂S, soaked clothing, or mixed-chemical residue requires decontamination. [3]

  • Serious exposures require monitoring for delayed pulmonary injury and neurologic sequelae, even after initial clinical recovery.

Triage, Observation, and Disposition

Use the pathway in sequence: A — serious features at any time; B — concerning symptoms or high-risk exposure; home/scene management only when both are negative.

A. Serious Features at Any Time Since Exposure

Use the serious-exposure pathway if any of the following occurred, even if now resolved:

  • Knockdown, loss of consciousness, or collapse

  • Apnea, respiratory depression, or CPR

  • Seizure, hypotension, or dysrhythmia

  • New confusion, ataxia, or another neurologic deficit

  • Hypoxemia

Obtain collateral history from rescuers or coworkers. Recovery does not make a patient with a Step A feature eligible for minor-exposure discharge.

Disposition: Urgent ED assessment and hospital admission.

Monitor serious inhalational exposures for at least 24 hours, because clinically significant pulmonary injury may develop after presentation. [3]

ICU care is appropriate for:

  • Respiratory failure or mechanical ventilation

  • Pulmonary edema or ARDS

  • Persistent shock

  • Seizures or coma

  • Post-cardiac-arrest care

  • Major dysrhythmia

Document a neurologic examination before discharge and arrange appropriate follow-up.

B. Concerning Symptoms or High-Risk Exposure

When no Step A feature has occurred, refer for ED assessment if any of the following is present:

  • Any dyspnea, chest tightness or pain, or wheeze since exposure, even if resolved

  • Persistent or recurrent cough

  • Marked eye irritation or eye injury

  • Any symptom that persists or worsens

  • Confined-space or underground exposure, or a coworker who collapsed or died

  • High-concentration exposure or circumstances in which substantial exposure cannot be excluded

  • Liquid contact

  • Intentional exposure or unreliable exposure history

Step B referral means ED assessment, not automatic admission.

Examine the chest and symptomatic eyes. Obtain chest imaging for respiratory symptoms or significant exposure and assess for systemic toxicity or co-exposures as indicated.

Escalate to the serious-exposure pathway if evaluation identifies hypoxemia, exposure-related chest-imaging abnormalities, significant bronchospasm, metabolic acidosis, or persistent respiratory symptoms.

For intentional exposure, arrange psychiatric assessment after medical stabilization. Evaluate possible co-ingestion and select testing according to the clinical findings and local self-poisoning protocol.

Discharge After ED Observation

Archived ATSDR guidance supports discharge after approximately 4–6 hours of observation when a patient is asymptomatic and has no evidence of pulmonary edema, CNS or respiratory compromise, or eye irritation. [3]

Observe for approximately 4–6 hours and extend the interval as clinically indicated, particularly when exposure intensity, timing, or other clinical factors are uncertain.

This is operational guidance, not a validated clearance threshold.

Discharge requires an appropriate clinical assessment, a reassuring observation course, and clear return precautions.

Home or Scene Management

MedicalToxic operational judgment — not a validated rule

Home or scene management may be considered after individualized poison-center assessment only when:

  • No serious feature in Step A has occurred.

  • No ED-referral criterion in Step B is present.

  • The exposure history is reliable.

  • The patient is currently asymptomatic or experienced only mild eye/throat irritation, headache, nausea, or dizziness that fully resolved after removal to fresh air.

  • Reliable follow-up and prompt access to emergency care are available.

ATSDR explicitly permits scene release after minor or transient eye or throat irritation. The broader eligibility criteria above represent MedicalToxic operational judgment. [3]

For patients managed outside the ED:

  • Remain in clean air.

  • Do not re-enter the exposure area until qualified safety personnel have cleared it.

  • Arrange poison-center follow-up and provide the discharge instructions below.

  • Reassess any new or recurrent symptom using Step A first, then Step B.

  • Severe symptoms require emergency medical assessment.

Observation Clock

MedicalToxic operational convention

Record:

  1. When the exposure ended.

  2. When clinical observation began.

For patients on a clinical observation pathway, count the observation period from the first clinical assessment after removal to clean air.

Unobserved time at home or in transit does not count toward the supervised observation period.

This convention does not require ED observation for patients who satisfy the individualized home/scene criteria.

Discharge Instructions — All Pathways

Call emergency medical services immediately for severe breathing difficulty, collapse, seizures, or acute confusion.

Seek prompt reassessment for any other new or worsening symptom, including cough, chest discomfort, weakness, imbalance, worsening eye pain, redness, or visual disturbance.

Watch particularly for delayed respiratory symptoms over the next 72 hours. Report new neurologic symptoms whenever they occur; delayed neurologic deterioration has been described after apparent initial recovery. [3,8,10]

Additional instructions:

  • Do not re-enter the exposure site until qualified personnel confirm that it is safe.

  • Avoid cigarette smoke for 72 hours. [3]

  • Arrange re-examination of significant eye or skin injury within 24 hours. [3]

  • After significant exposure, document the neurologic follow-up plan.

  • Address occupational reporting requirements and the possibility that other people remain exposed.

Exposure Sources and Scene Safety

Hydrogen sulfide is produced naturally and during industrial processes involving sulfur-containing material. [1–4]

Setting

Typical exposure

Sewers and wastewater systems

Manholes, sewer vaults, treatment plants, sludge tanks

Agriculture

Manure pits, slurry tanks, animal-waste systems, silos

Oil and gas

Wells, drilling, refining, tanks, sour-gas environments

Mining and underground work

Shafts, tunnels, pits, poorly ventilated spaces

Industrial processing

Pulp and paper, rayon, tanning, petrochemical and food-processing operations

Geothermal environments

Sulfur springs, hot-spring reservoirs

Confined spaces

Tanks, pits, vaults, and other spaces where gas may accumulate

Intentional generation

Hazardous chemical mixing in enclosed vehicles or rooms

H₂S is slightly heavier than air and may accumulate in low-lying or poorly ventilated areas. It is also flammable, so scene management must address both inhalation and ignition hazards. [1–3]

In the 2026 Taiwan Poison Control Center series, more than 70% of 168 reported cases involved occupational exposure. Confined-space and underground exposures were associated with more severe outcomes. [4]

Do Not Create a Second Victim

Assume that an unconscious person in a sewer, pit, tank, manure-storage area, or similar environment may be in a potentially lethal atmosphere.

Do not enter for an improvised rescue.

OSHA guidance emphasizes:

  • Trained confined-space rescue capability

  • Atmospheric testing before entry

  • Appropriate confined-space procedures

  • Continuous monitoring and ventilation when indicated

  • Suitable respiratory protection

  • Prepared rescue personnel and equipment [2]

NIOSH designates 100 ppm as immediately dangerous to life or health (IDLH). [1]

Entry into an IDLH or unknown atmosphere requires trained personnel using positive-pressure, full-face SCBA or an appropriately approved IDLH-capable supplied-air system.

An unknown concentration must never be assumed safe.

The NIOSH IDLH value is a responder-protection threshold, not a patient-severity or disposition cutoff.

Why Odor Cannot Be Trusted

Hydrogen sulfide has a characteristic rotten-egg odor at low concentrations.

However, continued or high-level exposure can rapidly impair the ability to detect that odor. [1–3]

“I can't smell it anymore” does not mean the atmosphere is safe.

Only appropriate atmospheric monitoring can establish conditions for safe entry.

Intentional Exposures

An enclosed vehicle or room, evidence of chemical mixing, or warning notes should trigger HAZMAT precautions.

Do not investigate the source, open suspect containers, or enter the area without appropriate protection.

Inform rescuers and the receiving facility about possible ongoing gas generation, contaminated surfaces, and chemical residue. [9]

Secondary Contamination

A patient exposed only to H₂S gas and removed into clean air generally presents little secondary-contamination risk to healthcare personnel. [3]

Risk may remain when:

  • Clothing is heavily soaked with H₂S-containing liquid.

  • Liquefied compressed H₂S has contaminated clothing or skin.

  • An unknown industrial mixture or chemical residue is present.

Communicate the exposure circumstances to EMS and the receiving hospital.

Decontamination

Decontamination should occur in parallel with lifesaving treatment.

Unnecessary decontamination must not delay airway or circulatory resuscitation.

Gas-Only Exposure

A patient exposed only to gas, without skin or eye irritation, generally requires no extensive decontamination once in clean air. [3]

Liquid H₂S, Soaked Clothing, or Chemical Residue

  • Remove contaminated clothing when safe.

  • Isolate and double-bag contaminated clothing according to HAZMAT procedures.

  • Wash exposed skin and hair with water.

  • Prevent hypothermia during decontamination, particularly in children and older adults.

  • Recognize that contaminated material may continue releasing hazardous gas.

Eye Exposure

For eye irritation after gas exposure, provided the ocular tissue is not frozen:

  • Remove contact lenses if easily removable.

  • Irrigate promptly with water or normal saline. ATSDR specifies at least 5 minutes; prolonged irrigation is appropriate when pain or irritation persists or a corrosive co-exposure is suspected. [3]

  • Assess visual acuity.

  • Examine for corneal injury.

  • Obtain ophthalmology assessment for persistent pain, visual impairment, or significant corneal injury.

Liquefied-gas exception: Direct contact with liquefied H₂S can cause frostbite.

Do not irrigate frostbitten eyes. Obtain urgent ophthalmology assessment and manage as a cold injury. [3]

Treat frostbitten skin using appropriate cold-injury care.

Mechanism and Clinical Presentation

At high concentrations, hydrogen sulfide inhibits mitochondrial oxidative metabolism, including cytochrome-c oxidase activity, impairing ATP production. It also affects neurologic and cardiovascular function and directly irritates the eyes and respiratory tract. [5,8]

The mechanism of sudden knockdown is probably more complex than mitochondrial inhibition alone. Clinically, the important consequence is that a patient may collapse with little warning following an intense exposure.

Severe poisoning can produce:

  • Cellular hypoxia

  • Lactate elevation and metabolic acidosis

  • Respiratory depression or apnea

  • Reduced myocardial function

  • Hypotension or dysrhythmia

  • Seizures and cerebral injury

  • Pulmonary irritation or edema

Severity depends on exposure concentration, duration, environment, and co-exposures.

The following groups are descriptive, not a validated severity score. Disposition follows the worst feature recorded since exposure and the A/B pathway.

Clinical group

Typical findings

Pathway

Local or mild nonspecific

Eye, nose, or throat irritation; tearing; mild headache, dizziness, or nausea

Home/scene only if no A or B criteria

Respiratory or ocular concern

Cough, dyspnea, chest tightness or pain, wheeze, marked eye irritation or injury

Step B: ED assessment

Serious systemic toxicity

Knockdown, collapse, apnea, respiratory depression, seizure, new confusion or ataxia, hypoxemia, hypotension, dysrhythmia, metabolic acidosis, significant pulmonary injury

Step A / serious-exposure pathway

Critical illness

Respiratory failure or arrest, shock, pulmonary edema/ARDS, coma, cardiac arrest, severe hypoxic or neurologic injury

Serious-exposure pathway; ICU

Rapid apparent recovery after knockdown does not establish a minor exposure.

New confusion and ataxia are serious features, not moderate ones.

History, Evaluation, and Differential Diagnosis

Focused History

Ask rescuers and coworkers when possible rather than relying only on the patient.

Determine:

  • Workplace and task

  • Confined-space or underground setting

  • Estimated exposure duration

  • Time exposure ended and first clinical assessment began

  • Atmospheric H₂S and oxygen measurements, if available

  • Other gas-monitor readings

  • Loss of consciousness, collapse, seizure, apnea, respiratory arrest, CPR, or any serious feature that occurred and resolved

  • Dyspnea, chest tightness or pain, or wheeze at any time

  • Persistent or recurrent cough

  • Other workers affected

  • Chemicals or industrial processes involved

  • Possible intentional generation

  • Possible cyanide, carbon monoxide, simple asphyxiants, or other industrial gases

  • Liquid exposure

  • Trauma during collapse

  • Treatments already administered

A cluster of suddenly collapsed workers strongly suggests a hazardous-atmosphere event and should trigger occupational and emergency-response investigation.

Evaluation and Testing

Diagnosis is primarily clinical and exposure-based.

Do not wait for a blood sulfide concentration before treatment. H₂S is rapidly metabolized, and direct blood measurements do not routinely guide acute management. [3,5]

For severe or symptomatic exposure, consider:

  • Continuous pulse oximetry

  • Cardiac monitoring and 12-lead ECG

  • Arterial or venous blood gas

  • Lactate

  • Electrolytes and bicarbonate

  • Glucose

  • Creatinine

  • Complete blood count

  • Chest radiography for respiratory symptoms or significant exposure

  • Creatine kinase after seizure, prolonged immobilization, or suspected muscle injury

  • Troponin when myocardial injury is suspected

Select additional investigations according to suspected trauma or co-exposure.

Acidosis and Lactate

Lower initial pH and bicarbonate were associated with severe-to-fatal poisoning in the 2026 Taiwan cohort. [4]

However, no pH, bicarbonate, or lactate threshold has been validated as a standalone treatment, disposition, or futility criterion for H₂S poisoning.

Treat the underlying physiologic failure rather than a single laboratory value.

Chest Imaging

Pulmonary infiltrates were strongly associated with severe-to-fatal outcomes in the Taiwan series. [4]

This association does not establish a validated prognostic rule.

An abnormal chest radiograph attributed to the exposure supports hospital admission and respiratory monitoring.

Differential Diagnosis

Depending on the exposure setting, consider:

  • Cyanide

  • Carbon monoxide

  • Oxygen-deficient or simple-asphyxiant atmosphere

  • Methemoglobinemia

  • Smoke inhalation

  • Hydrocarbon or solvent exposure

  • Other industrial gases

  • Unrelated seizures, syncope, or cardiac events

  • Trauma associated with collapse

Diagnostic Traps

“It smelled bad, then the smell went away.”

This is not reassurance. Odor perception may fail during continued hazardous exposure. [1–3]

“Pulse oximetry is normal.”

A normal SpO₂ does not exclude H₂S toxicity. Cellular oxygen utilization and neurologic or cardiovascular function may be impaired despite apparently acceptable peripheral oxygen saturation.

“This is basically cyanide poisoning.”

H₂S and cyanide share some toxicodynamic mechanisms, but their clinical evidence and antidote strategies differ.

Do not automatically administer cyanide antidotes solely because H₂S exposure is suspected.

For independently suspected cyanide poisoning, follow Cyanide Poisoning: Hydroxocobalamin, Antidotes, and Emergency Management.

Emergency Management

1. Safe Removal

Removing the patient from exposure is lifesaving—but only when performed by properly protected rescuers.

Do not compromise responder safety to accelerate patient contact.

2. Airway and Breathing

Give high-concentration supplemental oxygen to significantly symptomatic patients.

When spontaneous ventilation is inadequate:

  • Provide bag-mask ventilation.

  • Secure the airway when clinically required.

  • Provide mechanical ventilation according to standard critical-care principles.

Hydrogen sulfide may depress central respiratory drive and injure the lungs.

A normal SpO₂ does not necessarily establish adequate ventilation.

For general poisoned-patient stabilization, see Comprehensive Guidelines for Managing Poisoning in Adults.

3. Bronchospasm and Airway Irritation

Treat clinically significant bronchospasm with inhaled bronchodilators. [3]

Manage stridor, airway edema, or severe upper-airway irritation according to standard inhalational-injury principles.

4. Circulation

Treat hypotension with appropriate IV fluids.

Use vasopressors when clinically important shock persists despite appropriate initial resuscitation.

Continue cardiac monitoring because severe poisoning can impair myocardial function and produce dysrhythmias.

5. Seizures

Treat seizures promptly, generally beginning with a benzodiazepine according to standard toxicologic seizure protocols.

Correct hypoxia and hypoglycemia, and evaluate for trauma or toxic co-exposure.

Cardiac Arrest

Rescuer protection remains essential.

Once the patient is safely removed:

  • Begin high-quality CPR.

  • Establish effective ventilation.

  • Provide high-concentration oxygen.

  • Follow current ACLS/PALS principles.

  • Treat conventional reversible causes.

There is no proven H₂S-specific cardiac-arrest antidote.

Do not delay CPR, airway management, or oxygenation while preparing sodium nitrite or another investigational adjunct.

Pulmonary Injury

H₂S is a direct respiratory irritant.

Severe exposure can cause:

  • Bronchitis

  • Bronchospasm

  • Pneumonitis

  • Noncardiogenic pulmonary edema

  • Acute respiratory distress syndrome (ARDS)

Pulmonary injury can evolve after the patient leaves the exposure area. [3]

Treatment follows standard respiratory and critical-care principles:

  • Oxygen supplementation

  • Inhaled bronchodilators when bronchospasm is present

  • Positive-pressure ventilation when required

  • Lung-protective mechanical ventilation for ARDS

No H₂S-specific diuretic or corticosteroid regimen has demonstrated clinical benefit.

Metabolic Acidosis

Correct inadequate oxygenation, ventilation, perfusion, and shock.

Sodium bicarbonate is not an H₂S antidote.

It may be considered for severe persistent acidemia according to general critical-care or toxicology principles, but must never distract from definitive supportive resuscitation.

Sodium Nitrite and Other Adjuncts

Sodium Nitrite: Unproven and Controversial

Nitrite therapy has historically been proposed because methemoglobin can bind sulfide and potentially create a circulating sulfide sink. [3,6,7]

Clinical evidence remains limited to uncontrolled reports and nondefinitive observational data.

The archived ATSDR guidance recommends considering nitrite if it can be started very shortly after exposure, while explicitly acknowledging anecdotal evidence and uncertainty beyond the first few minutes. It also emphasizes that nitrite must not interfere with ventilation or oxygenation. [3]

MedicalToxic takes a more restrictive position because benefit is unproven, the proposed treatment window is extremely short, and nitrite can cause methemoglobinemia and hypotension.

In the 2026 Taiwan cohort, nitrite administered before out-of-hospital cardiac arrest was associated with lower adjusted odds of death, but the association was not statistically significant:

Adjusted OR 0.43; P=0.49. [4]

This does not demonstrate a mortality benefit.

MedicalToxic clinical position

  • Do not administer sodium nitrite routinely for H₂S poisoning.

  • For a very recent, life-threatening exposure, discuss possible use urgently with a poison center or medical toxicologist.

  • Never delay protected removal, oxygen, ventilation, CPR, or cardiovascular resuscitation to administer nitrite.

  • If nitrite is used under expert direction, monitor methemoglobin by co-oximetry and monitor hemodynamics closely.

No routine sodium-nitrite dosing order set is provided because efficacy is not established.

Do Not Automatically Transfer Cyanide Antidotes

Mechanistic similarity does not establish therapeutic equivalence.

Sodium thiosulfate

Its established role in cyanide poisoning does not translate into proven benefit in H₂S poisoning. Routine use for isolated H₂S exposure is unsupported.

Hydroxocobalamin

Experimental and isolated human reports exist, but reliable clinical evidence establishing efficacy for H₂S poisoning is lacking. Do not administer it routinely solely for H₂S exposure. [5,9]

Methylene blue and other sulfide countermeasures

Preclinical and animal studies have explored several agents, but none is established as standard human H₂S therapy. [5,9]

If cyanide is independently suspected, treat it according to the cyanide-specific pathway.

Hyperbaric Oxygen

Hyperbaric oxygen therapy (HBOT) for severe H₂S poisoning is supported mainly by case reports and limited observational experience.

Routine HBOT is not evidence-based. [3,5]

Case-specific discussion with medical toxicology and hyperbaric specialists may be reasonable for persistent coma or major neurologic dysfunction after initial cardiopulmonary stabilization, provided that transport does not compromise critical care.

Enhanced Elimination

Hemodialysis, hemoperfusion, and other extracorporeal toxin-removal strategies have no established routine role in H₂S poisoning.

H₂S is rapidly redistributed and metabolized.

Renal replacement therapy remains appropriate for conventional organ-support indications, not as routine H₂S removal.

Neurologic Sequelae, Special Populations, and Occupational Follow-Up

Neurologic Sequelae

Survivors of severe H₂S poisoning may develop persistent or delayed:

  • Memory or concentration difficulties

  • Ataxia or movement abnormalities

  • Dysarthria

  • Hearing impairment

  • Headache

  • Sleep disturbance

  • Behavioral or neuropsychiatric symptoms

Long-term neurologic complications have been documented, and deterioration after initial recovery of consciousness has been described. [8,10]

Patients experiencing knockdown, coma, seizures, respiratory arrest, prolonged hypoxia, or objective neurologic abnormalities should receive a documented neurologic assessment before discharge.

Persistent symptoms may justify:

  • Neurology referral

  • Neuropsychological testing

  • Hearing assessment

  • Rehabilitation

  • Neuroimaging when indicated

No validated universal schedule exists for long-term neurologic surveillance. [8]

Children

Children may inhale a greater amount relative to body weight and may be physically closer to gas accumulating near ground level.

Smaller airways may also increase vulnerability to irritant injury. [3]

Management principles are otherwise the same:

  • Protect rescuers.

  • Remove the patient safely.

  • Support airway and ventilation.

  • Provide oxygen.

  • Treat seizures and shock using established pediatric resuscitation principles.

  • Observe significant exposures in an appropriate healthcare setting.

No pediatric H₂S-specific antidote regimen is established.

Pregnancy

Maternal stabilization is the immediate priority.

Treat respiratory failure, hypoxemia, hypotension, seizures, and cardiac arrest aggressively according to appropriate maternal-resuscitation principles.

There is no proven pregnancy-specific H₂S antidote.

Occupational Follow-Up and Prevention

A workplace H₂S poisoning should trigger investigation beyond the individual patient.

Review:

  • Atmospheric monitoring

  • Confined-space permits and entry procedures

  • Ventilation

  • Alarm and detection systems

  • Respiratory protection

  • Rescue procedures

  • Standby personnel

  • Worker training

  • Whether other employees remain at risk

OSHA emphasizes testing atmospheres before entry, monitoring during work, continuous ventilation when indicated, trained attendants, rescue planning, and appropriate positive-pressure respiratory protection for hazardous atmospheres. [2]

Occupational and public-health reporting requirements vary by jurisdiction.

Evidence Update: What the 2026 Taiwan Cohort Adds

Wen and colleagues conducted a retrospective review of 168 patients reported to the Taiwan Poison Control Center between 1986 and 2021; the results were published in 2026. [4]

Three findings are clinically important.

First, occupational exposure predominated. More than 70% of cases were occupational, emphasizing the importance of workplace prevention and responder safety.

Second, exposure environment influenced risk. Confined-space and underground exposures were associated with severe-to-fatal outcomes.

Third, early clinical abnormalities were informative. Metabolic acidosis and pulmonary infiltrates were associated with severe-to-fatal poisoning.

The study does not:

  • Validate a new severity score.

  • Establish a universal pH or bicarbonate treatment threshold.

  • Prove sodium nitrite reduces mortality.

  • Justify routine nitrite administration.

  • Establish a validated disposition algorithm.

The sodium-nitrite finding is hypothesis-generating.

Referral patterns, treatment selection, exposure severity, and changes in clinical practice across 35 years limit causal interpretation.

Common Clinical Pitfalls

Pitfall

Correct approach

Entering a confined space without respiratory protection to rescue the patient

Do not enter without trained rescue capability and appropriate SCBA

Using smell to judge atmospheric safety

Odor is unreliable; use appropriate gas monitoring

Delaying ventilation to prepare an antidote

Oxygenation and ventilation come first

Treating H₂S exactly like cyanide

Similar mechanisms do not establish the same antidotal evidence

Administering sodium nitrite routinely

Efficacy is unproven; reserve consideration for urgent expert risk–benefit discussion

Assuming normal SpO₂ excludes serious toxicity

Cellular, neurologic, and cardiovascular toxicity may occur despite acceptable SpO₂

Discharging a patient after recovery from knockdown

Use the serious-exposure pathway even if currently asymptomatic

Sending home a patient whose dyspnea has resolved

Any dyspnea, chest tightness, or wheeze since exposure requires ED assessment

Missing contamination from soaked clothing or chemical residue

Remove contaminated clothing and decontaminate safely

Treating an occupational incident as a single-patient problem

Address ongoing site hazards and other potentially exposed workers

Key Final Message

In hydrogen sulfide poisoning, safe rescue is part of medical treatment.

A patient who recovers from knockdown still has a history of serious exposure.

A serious feature at any time determines the high-risk pathway.

Airway, ventilation, oxygenation, and cardiovascular support remain the established treatment.

No antidote has proven clinical efficacy. Sodium nitrite is an uncertain adjunct, not routine care.

Monitor serious exposures for evolving pulmonary injury and arrange appropriate neurologic follow-up.

References:

  1. National Institute for Occupational Safety and Health. Hydrogen sulfide — NIOSH Pocket Guide to Chemical Hazards. Centers for Disease Control and Prevention. Accessed November 8, 2026
  2. Occupational Safety and Health Administration. Hydrogen Sulfide — Evaluating and Controlling Exposure. U.S. Department of Labor. Accessed November 8, 2026
  3. Agency for Toxic Substances and Disease Registry. Medical Management Guidelines for Hydrogen Sulfide. CDC Toxic Substance Portal. Archived clinical guidance; accessed November 8, 2026
  4. Wen YC, Chu FY, Wang TH, Deng JF, Yang CC. Analysis of patients with hydrogen sulfide poisoning reported to the Taiwan Poison Control Center between 1986 and 2021. Clinical Toxicology (Philadelphia). 2026;64(10):933–942 https://doi.org/10.1080/15563650.2026.2675040
  5. Santana Maldonado C, Weir A, Rumbeiha WK. A comprehensive review of treatments for hydrogen sulfide poisoning: past, present, and future. Toxicology Mechanisms and Methods. 2023;33(3):183–196 https://doi.org/10.1080/15376516.2022.2121192
  6. Guidotti TL. Hydrogen sulfide intoxication. Handbook of Clinical Neurology. 2015;131:111–133 https://doi.org/10.1016/B978-0-444-62627-1.00008-1
  7. Hall AH, Rumack BH. Hydrogen sulfide poisoning: an antidotal role for sodium nitrite?. Veterinary and Human Toxicology. 1997;39(3):152–154. PMID:9167244
  8. Rumbeiha WK, Kim DS. Neurological Sequelae of Acute Hydrogen Sulfide Poisoning: A Literature Review, Controversies, and Knowledge Gaps. Neurology International. 2025;17(5):71 https://doi.org/10.3390/neurolint17050071
  9. Ng PC, Hendry-Hofer TB, Witeof AE, Brenner M, Mahon SB, Boss GR, et al. Hydrogen Sulfide Toxicity: Mechanism of Action, Clinical Presentation, and Countermeasure Development. Journal of Medical Toxicology. 2019;15(4):287–294 https://doi.org/10.1007/s13181-019-00710-5
  10. Tvedt B, Edland A, Skyberg K, Forberg O. Delayed neuropsychiatric sequelae after acute hydrogen sulfide poisoning: affection of motor function, memory, vision and hearing. Acta Neurologica Scandinavica. 1991;84(4):348–351 https://doi.org/10.1111/j.1600-0404.1991.tb04967.x
Medical ToxicologyRetrieved from https://medicaltoxic.com/guidelines/hydrogen-sulfide-poisoning-management© All copyright of this material is absolute to Medical Toxicology.For professional educational use only. This content does not replace clinical judgment or consultation with a poison control center.
Medical Toxicology
Table of Contents
Emergency PathwayKey Clinical TakeawaysTriage, Observation, and DispositionA. Serious Features at Any Time Since ExposureB. Concerning Symptoms or High-Risk ExposureDischarge After ED ObservationHome or Scene ManagementObservation ClockDischarge Instructions — All PathwaysExposure Sources and Scene SafetyDo Not Create a Second VictimWhy Odor Cannot Be TrustedIntentional ExposuresSecondary ContaminationDecontaminationGas-Only ExposureLiquid H₂S, Soaked Clothing, or Chemical ResidueEye ExposureMechanism and Clinical PresentationHistory, Evaluation, and Differential DiagnosisFocused HistoryEvaluation and TestingAcidosis and LactateChest ImagingDifferential DiagnosisDiagnostic TrapsEmergency Management1. Safe Removal2. Airway and Breathing3. Bronchospasm and Airway Irritation4. Circulation5. SeizuresCardiac ArrestPulmonary InjuryMetabolic AcidosisSodium Nitrite and Other AdjunctsSodium Nitrite: Unproven and ControversialDo Not Automatically Transfer Cyanide AntidotesHyperbaric OxygenEnhanced EliminationNeurologic Sequelae, Special Populations, and Occupational Follow-UpNeurologic SequelaeChildrenPregnancyOccupational Follow-Up and PreventionEvidence Update: What the 2026 Taiwan Cohort AddsCommon Clinical PitfallsKey Final Message

Newsletter

Stay current on toxicology

New guidelines, case studies, and product updates — straight to your inbox.

Medical Toxicology

Empowering healthcare professionals with advanced tools and comprehensive information to manage poisoning incidents effectively.

Explore

  • Products
  • Guidelines
  • Blogs
  • News
  • Case studies
  • Tox Spotlight
  • About us

Platform

  • ToxLumen
  • Community
  • CMS
  • Account Management
  • Support

Legal

  • Privacy Policy
  • Terms

© Medical Toxicology LLC. All rights reserved.